PHYSIOLOGICAL SKIN REPLACEMENT

Information

  • Research Project
  • 3490703
  • ApplicationId
    3490703
  • Core Project Number
    R43AR041110
  • Full Project Number
    1R43AR041110-01
  • Serial Number
    41110
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1991 - 34 years ago
  • Project End Date
    2/29/1992 - 33 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1991 - 34 years ago
  • Budget End Date
    2/29/1992 - 33 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/24/1991 - 34 years ago

PHYSIOLOGICAL SKIN REPLACEMENT

DESCRIPTION: (Adapted from the applicant's abstract) A novel physiologic skin mode has been developed utilizing human neonatal dermal fibroblasts cultured on a biodegradable, polyglycolic or polyglactic acid, mesh. The proliferating cells stretch across the mesh opening and secrete native growth factors, collagens and other extracellular matrix proteins to produce an in vitro human dermal tissue. Human keratinocytes can also be cultured onto this dermal tissue to form a living cultured skin with both dermal and epidermal components. Preliminary studies in mini-pigs and athymic mice indicate that the cultured dermis can rapidly adhere to full-thickness wounds, vascularize, and support epithelial coverage and wound closure with reduced wound contraction and scarring. Dermal tissue has been widely reported not to be immunologically rejected. The technology described here offers the potential for a universal dermal replacement that could be used under thin autologous epidermal grafts or widely-meshed grafts, or as a base for cultured, autologous keratinocytes to form a composite skin substitute. Support of this gran would allow further in vitro characterization of the cultured skin model and additional pre-clinical studies to optimize its application in therapeutic skin replacement. These studies are expected to lead directly to clinical trials in patients with full-thickness skin wounds.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    GMA
  • Study Section Name
    General Medicine A Subcommittee 2
  • Organization Name
    ADVANCED TISSUE SCIENCES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LA JOLLA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92037
  • Organization District
    UNITED STATES